Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Public ClinicalTrials.gov record NCT05397639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Study identification
- NCT ID
- NCT05397639
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 375 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2022 (Actual)
- Primary completion
- Dec 2026 (Estimated)
- Completion
- Dec 2026 (Estimated)
- Last update posted
- Sep 15, 2026
2022 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research Center, Inc. | Anaheim | California | 92805-5854 | — |
| ATP Clinical Research, Inc. | Costa Mesa | California | 92626-4607 | — |
| Leading Edge Research LA, LLC | Encino | California | 91316 | — |
| Neuro Pain Medical Center | Fresno | California | 93710-5473 | — |
| Neurology Center of North Orange County | Fullerton | California | 92835-1040 | — |
| Mary S Easton Center for Alzheimer's Research and Care UCLA | Los Angeles | California | 90095 | — |
| Ki Health Partners, LLC | Stamford | Connecticut | 06905 | — |
| Allied Biomedical Research Institute | Miami | Florida | 33125-2607 | — |
| Central Miami Medical Institute | Miami | Florida | 33125 | — |
| CCM Clinical Research Group | Miami | Florida | 33133 | — |
| Miami Jewish Health | Miami | Florida | 33137 | — |
| Novel Clinical Research Center, LLC. | Miami | Florida | 33143 | — |
| Brainstorm Research | Miami | Florida | 33176 | — |
| Combined Research Orlando Phase I-IV | Orlando | Florida | 32807 | — |
| Quantum Laboratories Inc | Pompano Beach | Florida | 33064 | — |
| Re:Cognition Health | Chicago | Illinois | 60611 | — |
| Insight Hospital and Medical Center Chicago | Chicago | Illinois | 60616 | — |
| Ocean Medical Research | Toms River | New Jersey | 08755 | — |
| Dent Neurologic Institute | Amherst | New York | 14226 | — |
| Velocity Clinical Research, Syracuse | East Syracuse | New York | 13057 | — |
| Velocity Clinical Research, Cleveland | Beachwood | Ohio | 44122 | — |
| Ralph H. Johnson VA Health Care System | Charleston | South Carolina | 29401-1113 | — |
| Midlands Neurology and Pain Associates | Columbia | South Carolina | 29205 | — |
| Gadolin Research | Beaumont | Texas | 77702 | — |
| Re:Cognition Health | Fort Worth | Texas | 76104 | — |
| Baylor College of Medicine | Houston | Texas | 77030-4202 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05397639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05397639 live on ClinicalTrials.gov.